Healthcare Industry - Medical - Pharmaceutical - Biotech in Boston, United States

As the first and only industry-led forum dedicated to tackling the most pressing challenges when delivering RNA-based drugs, the 2nd Annual Non-Viral RNA Delivery Systems Summit is set to unite 50+ key thought leaders in biopharma and academia eager to help RNA vacci ..

There's significant momentum in the clinical and preclinical pipeline for dry AMD, backed by record-breaking investments and acquisitions. This was further demonstrated by the landmark first approval in February this year. The question for the field now is - what's n ..

Accelerating Patient Access to Early and Affordable Detection and Surveillance Tests The 2nd Liquid Biopsy Surveillance and Early Detection Summit returns as industry's only meeting showcasing biopharma-led case studies and assay developer technical progress to cr ..

Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the potential that gene therapies can act as transformative medicines within the CNS community. ..

The Dermatology Drug Development Summit returns for its 7th year as the largest industry focused summit dedicated to advancing treatment options across Atopic Dermatitis, Alopecia Areata, Hidradenitis suppurativa, Prurigo Nodularis and Vitiligo to name a few. From ..

This Fall, the world's longest-standing and most comprehensive TPD meeting, the 6th TPD Summit, returns to Boston in 2023 as the trusted, definitive, end-to-end forum for the global network of protein degradation drug developers. Ensure your whole team stays connect ..

The HER2 space continues to storm ahead of other oncology fields due to the overwhelming success of Enhertu and the continued satisfaction with Herceptin. As we enter 2023, the field shows no sign of slowing down and it is turning its attention to non-breast cancer t ..